Orbimed Advisors - THESEUS PHARMACEUTICALS INC ownership

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 52 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of THESEUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$47,649,584
-70.4%
17,713,600
+2.8%
1.01%
-65.3%
Q2 2023$160,790,122
+5.1%
17,233,6680.0%2.91%
-3.0%
Q1 2023$153,034,972
+78.3%
17,233,6680.0%3.00%
+82.9%
Q4 2022$85,823,667
-13.2%
17,233,668
+1.1%
1.64%
-10.5%
Q3 2022$98,842,000
+4.9%
17,041,6680.0%1.84%
+7.4%
Q2 2022$94,240,000
-52.0%
17,041,6680.0%1.71%
-46.4%
Q1 2022$196,490,000
-8.0%
17,041,668
+1.2%
3.19%
+16.1%
Q4 2021$213,514,00016,838,6682.74%
Other shareholders
THESEUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Opportunity Management V, LLC 959,275$5,564,00016.70%
Foresite Capital Management V, LLC 3,335,346$19,345,00014.87%
Lynx1 Capital Management LP 504,862$2,928,0002.64%
Orbimed Advisors 17,041,668$98,842,0001.84%
Omega Fund Management, LLC 711,479$4,127,0001.51%
Nextech Invest Ltd. 611,310$3,546,0001.14%
Opaleye Management Inc. 220,650$1,280,0000.53%
Boxer Capital, LLC 892,057$5,174,0000.29%
DAFNA Capital Management LLC 81,899$475,0000.13%
Rock Springs Capital Management LP 437,329$2,537,0000.07%
View complete list of THESEUS PHARMACEUTICALS INC shareholders